The launch of a 750mcg parathyroid hormone injection in Australia has been somewhat restricted , with distribution primarily to specialist physicians and designated clinics . Early distribution numbers for this higher dosage remain unavailable from the company, although experts suggest gradual adoption penetration. Distribution to individuals is go